Satvat Ali J. bought BBIO
June 22, 2026 · Form 4 insider transaction
Satvat Ali J. bought 3,990 shares of BridgeBio Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,990
Price
$0.00
Total value
N/A
InsiderSatvat Ali J.
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after169,983
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.; Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.